Exceeding predefined thresholds for MRI bone oedema and erosion and HAQ-di can predict relapse after withdrawal of all treatment in MTX-naÏve patients with RA in remission after 12 months of abatacept therapy in the avert trial

H A Ahmad; J F Baker; Mikkel Østergaard; P Emery; T Huizinga; Y Elbez; S Banerjee; P G Conaghan

Exceeding predefined thresholds for MRI bone oedema and erosion and HAQ-di can predict relapse after withdrawal of all treatment in MTX-naÏve patients with RA in remission after 12 months of abatacept therapy in the avert trial

H A Ahmad, J F Baker, Mikkel Østergaard, P Emery, T Huizinga, Y Elbez, S Banerjee, P G Conaghan

Afdeling for Rygkirurgi, Led- og Bindevævssygdomme

Originalsprog	Engelsk
Artikelnummer	FRI0044
Tidsskrift	Annals of the Rheumatic Diseases
Vol/bind	77
Udgave nummer	Suppl. 2
Sider (fra-til)	568-9
Antal sider	2
ISSN	0003-4967
Status	Udgivet - 2018

Citationsformater

Ahmad, H. A., Baker, J. F., Østergaard, M., Emery, P., Huizinga, T., Elbez, Y., Banerjee, S., & Conaghan, P. G. (2018). Exceeding predefined thresholds for MRI bone oedema and erosion and HAQ-di can predict relapse after withdrawal of all treatment in MTX-naÏve patients with RA in remission after 12 months of abatacept therapy in the avert trial. Annals of the Rheumatic Diseases, 77(Suppl. 2), 568-9. Artikel FRI0044.

Exceeding predefined thresholds for MRI bone oedema and erosion and HAQ-di can predict relapse after withdrawal of all treatment in MTX-naÏve patients with RA in remission after 12 months of abatacept therapy in the avert trial. / Ahmad, H A; Baker, J F; Østergaard, Mikkel et al.
I: Annals of the Rheumatic Diseases, Bind 77, Nr. Suppl. 2, FRI0044, 2018, s. 568-9.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Ahmad, HA, Baker, JF, Østergaard, M, Emery, P, Huizinga, T, Elbez, Y, Banerjee, S & Conaghan, PG 2018, 'Exceeding predefined thresholds for MRI bone oedema and erosion and HAQ-di can predict relapse after withdrawal of all treatment in MTX-naÏve patients with RA in remission after 12 months of abatacept therapy in the avert trial', Annals of the Rheumatic Diseases, bind 77, nr. Suppl. 2, FRI0044, s. 568-9.

@article{d61f89d63749439b8debb57486f73aea,

title = "Exceeding predefined thresholds for MRI bone oedema and erosion and HAQ-di can predict relapse after withdrawal of all treatment in MTX-na{\"I}ve patients with RA in remission after 12 months of abatacept therapy in the avert trial",

author = "Ahmad, {H A} and Baker, {J F} and Mikkel {\O}stergaard and P Emery and T Huizinga and Y Elbez and S Banerjee and Conaghan, {P G}",

note = "COPECARE",

year = "2018",

language = "English",

volume = "77",

pages = "568--9",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "Elsevier BV",

number = "Suppl. 2",

}

TY - ABST

T1 - Exceeding predefined thresholds for MRI bone oedema and erosion and HAQ-di can predict relapse after withdrawal of all treatment in MTX-naÏve patients with RA in remission after 12 months of abatacept therapy in the avert trial

AU - Ahmad, H A

AU - Baker, J F

AU - Østergaard, Mikkel

AU - Emery, P

AU - Huizinga, T

AU - Elbez, Y

AU - Banerjee, S

AU - Conaghan, P G

N1 - COPECARE

PY - 2018

Y1 - 2018

M3 - Conference abstract in journal

SN - 0003-4967

VL - 77

SP - 568

EP - 569

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Suppl. 2

M1 - FRI0044

ER -